Skip to main
INSP

INSP Stock Forecast & Price Target

INSP Analyst Ratings

Based on 15 analyst ratings
Hold
Strong Buy 13%
Buy 20%
Hold 60%
Sell 0%
Strong Sell 7%

Bulls say

Inspire Medical Systems is a promising medical technology company with a strong focus on the development and commercialization of their innovative Inspire system, a neurostimulation technology for the treatment of obstructive sleep apnea (OSA). The company has a solid presence in the US and international markets and is looking to expand further. Despite recent challenges in the coding and reimbursement landscape, the company's efforts to mitigate these uncertainties and the launch of their next-gen Inspire V device could drive a return to growth in 2027. With a strong product pipeline and potential for increased adoption, INSP is a Buy for long-term investors.

Bears say

Inspire Medical Systems is facing numerous obstacles that impact its fundamental outlook. The company's recent attempts to secure a new code for HGNS have been unsuccessful, and its current coding and reimbursement situation is uncertain. Additionally, the company has cut its revenue and EPS guidance for 2026, and there are potential risks to its market share and profitability from competition and alternative OSA treatment modalities. All of these factors contribute to a negative outlook on the company's stock.

INSP has been analyzed by 15 analysts, with a consensus rating of Hold. 13% of analysts recommend a Strong Buy, 20% recommend Buy, 60% suggest Holding, 0% advise Selling, and 7% predict a Strong Sell.

This aggregate rating is based on analysts' research of Inspire Medical Systems Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Inspire Medical Systems Inc (INSP) Forecast

Analysts have given INSP a Hold based on their latest research and market trends.

According to 15 analysts, INSP has a Hold consensus rating as of Sep 22, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $75.87, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $75.87, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Inspire Medical Systems Inc (INSP)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.